• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

因子VIII被活化蛋白C和蛋白S灭活。

Inactivation of factor VIII by activated protein C and protein S.

作者信息

Walker F J, Chavin S I, Fay P J

出版信息

Arch Biochem Biophys. 1987 Jan;252(1):322-8. doi: 10.1016/0003-9861(87)90037-3.

DOI:10.1016/0003-9861(87)90037-3
PMID:2949697
Abstract

Factor VIII was inactivated by activated protein C in the presence of calcium and phospholipids. Analysis of the activated protein C-catalyzed cleavage products of factor VIII indicated that inactivation resulted from the cleavage of the heavy chains. The heavy chains appeared to be converted into 93- and 53-kDa peptides. Inactivation of factor VIII that was only composed of the 93-kDa heavy chain and 83-kDa light chain indicated that the 93-kDa polypeptide could be degraded into a 68-kDa peptide that could be subsequently cleaved into 48- and 23-kDa polypeptides. Thus, activated protein C catalyzed a minimum of four cleavages in the heavy chain. Activated protein C did not appear to alter the factor VIII light chain. The addition of protein S accelerated the rate of inactivation and the rate of all of the cleavages. The effect of protein S could be observed on the cleavage of the heavy chains and on secondary cleavages of the smaller products, including the 93-, 68-, and 53-kDa polypeptides. The addition of factor IX to the factor VIII-activated protein C reaction mixture resulted in the inhibition of factor VIII inactivation. The effect of factor IX was dose dependent. Factor VIII was observed to compete with factor Va for activated protein C. The concentration dependence of factor VIII inhibition of factor Va inactivation suggested that factor VIII and factor Va were equivalent substrates for activated protein C.

摘要

在钙和磷脂存在的情况下,凝血因子VIII被活化蛋白C灭活。对活化蛋白C催化的凝血因子VIII裂解产物的分析表明,灭活是由重链的裂解导致的。重链似乎被转化为93 kDa和53 kDa的肽段。仅由93 kDa重链和83 kDa轻链组成的凝血因子VIII的灭活表明,93 kDa的多肽可降解为68 kDa的肽段,随后可裂解为48 kDa和23 kDa的多肽。因此,活化蛋白C催化重链至少发生四次裂解。活化蛋白C似乎并未改变凝血因子VIII的轻链。蛋白S的添加加速了灭活速率以及所有裂解的速率。蛋白S的作用可在重链的裂解以及较小产物(包括93 kDa、68 kDa和53 kDa多肽)的二次裂解中观察到。向凝血因子VIII - 活化蛋白C反应混合物中添加凝血因子IX导致凝血因子VIII灭活受到抑制。凝血因子IX的作用呈剂量依赖性。观察到凝血因子VIII与因子Va竞争活化蛋白C。凝血因子VIII对因子Va灭活的抑制作用的浓度依赖性表明,凝血因子VIII和因子Va是活化蛋白C的等效底物。

相似文献

1
Inactivation of factor VIII by activated protein C and protein S.因子VIII被活化蛋白C和蛋白S灭活。
Arch Biochem Biophys. 1987 Jan;252(1):322-8. doi: 10.1016/0003-9861(87)90037-3.
2
Inactivation of human factor VIII by activated protein C: evidence that the factor VIII light chain contains the activated protein C binding site.活化蛋白C对人凝血因子VIII的灭活作用:凝血因子VIII轻链含有活化蛋白C结合位点的证据。
Biochim Biophys Acta. 1989 Feb 2;994(2):142-8. doi: 10.1016/0167-4838(89)90153-2.
3
The effect of phospholipids, calcium ions and protein S on rate constants of human factor Va inactivation by activated human protein C.
Eur J Biochem. 1992 Aug 15;208(1):171-8. doi: 10.1111/j.1432-1033.1992.tb17171.x.
4
Factor IXa protects activated factor VIII against inactivation by activated protein C.
Biochem Biophys Res Commun. 1984 Nov 30;125(1):177-83. doi: 10.1016/s0006-291x(84)80351-4.
5
Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor VaR506Q by activated protein C.活化蛋白C使因子Va和因子VaR506Q失活过程中的肽键断裂及功能活性丧失。
J Biol Chem. 1995 Sep 8;270(36):21158-66. doi: 10.1074/jbc.270.36.21158.
6
Mechanisms of plasmin-catalyzed inactivation of factor VIII: a crucial role for proteolytic cleavage at Arg336 responsible for plasmin-catalyzed factor VIII inactivation.纤溶酶催化因子VIII失活的机制:在精氨酸336处的蛋白水解切割对纤溶酶催化因子VIII失活起关键作用。
J Biol Chem. 2007 Feb 23;282(8):5287-95. doi: 10.1074/jbc.M607816200. Epub 2006 Dec 21.
7
Factor IXa and von Willebrand factor modify the inactivation of factor VIII by activated protein C.因子IXa和血管性血友病因子可改变活化蛋白C对因子VIII的灭活作用。
J Lab Clin Med. 1990 Apr;115(4):415-21.
8
Factor Va is inactivated by activated protein C in the absence of cleavage sites at Arg-306, Arg-506, and Arg-679.在精氨酸-306、精氨酸-506和精氨酸-679处不存在切割位点的情况下,凝血因子Va会被活化蛋白C灭活。
J Biol Chem. 2004 Feb 20;279(8):6567-75. doi: 10.1074/jbc.M308574200. Epub 2003 Dec 2.
9
The effect of Arg306-->Ala and Arg506-->Gln substitutions in the inactivation of recombinant human factor Va by activated protein C and protein S.精氨酸306突变为丙氨酸以及精氨酸506突变为谷氨酰胺对活化蛋白C和蛋白S使重组人因子Va失活的影响。
Protein Sci. 1997 Sep;6(9):2016-27. doi: 10.1002/pro.5560060922.
10
Functional properties of factor Va subunits after proteolytic alterations by activated protein C.
Biochim Biophys Acta. 1984 May 25;799(1):38-44. doi: 10.1016/0304-4165(84)90324-6.

引用本文的文献

1
Calumenin, A Calcium-Binding Modulatory Protein, Effective in Pathological Calcifications and Cancers, With Therapeutic Application Promise.钙网蛋白,一种钙结合调节蛋白,对病理性钙化和癌症有效,具有治疗应用前景。
FASEB Bioadv. 2025 Oct 13;7(10):e70056. doi: 10.1096/fba.2025-00106. eCollection 2025 Oct.
2
Pre-clinical evaluation of an enhanced-function factor VIII variant for durable hemophilia A gene therapy in male mice.增强功能因子 VIII 变异体在雄性小鼠中用于持久血友病 A 基因治疗的临床前评估。
Nat Commun. 2024 Aug 21;15(1):7193. doi: 10.1038/s41467-024-51296-8.
3
Activated protein C has a regulatory role in factor VIII function.
活化蛋白 C 在因子 VIII 功能中具有调节作用。
Blood. 2021 May 6;137(18):2532-2543. doi: 10.1182/blood.2020007562.
4
Modulation of protein S and growth arrest specific 6 protein signaling inhibits pancreatic cancer cell survival and proliferation.蛋白 S 和生长停滞特异性蛋白 6 信号的调节抑制胰腺癌细胞的存活和增殖。
Oncol Rep. 2020 Oct;44(4):1322-1332. doi: 10.3892/or.2020.7689. Epub 2020 Jul 15.
5
The Pros1/Tyro3 axis protects against periodontitis by modulating STAT/SOCS signalling.ProS1/Tyro3 轴通过调节 STAT/SOCS 信号转导来预防牙周炎。
J Cell Mol Med. 2019 Apr;23(4):2769-2781. doi: 10.1111/jcmm.14183. Epub 2019 Feb 7.
6
Understanding the functional difference between growth arrest-specific protein 6 and protein S: an evolutionary approach.了解生长停滞特异性蛋白6与蛋白S之间的功能差异:一种进化方法。
Open Biol. 2014 Oct;4(10). doi: 10.1098/rsob.140121.
7
A genome-wide association study of the Protein C anticoagulant pathway.一项关于蛋白 C 抗凝途径的全基因组关联研究。
PLoS One. 2011;6(12):e29168. doi: 10.1371/journal.pone.0029168. Epub 2011 Dec 28.
8
Zn²(+) -containing protein S inhibits extrinsic factor X-activating complex independently of tissue factor pathway inhibitor.含 Zn²⁺ 的蛋白质 S 可独立于组织因子途径抑制剂抑制外源性 X 因子激活复合物。
J Thromb Haemost. 2010 Sep;8(9):1976-85. doi: 10.1111/j.1538-7836.2010.03919.x.
9
Surface-mediated control of blood coagulation: the role of binding site densities and platelet deposition.表面介导的血液凝固控制:结合位点密度和血小板沉积的作用。
Biophys J. 2001 Mar;80(3):1050-74. doi: 10.1016/S0006-3495(01)76085-7.
10
Glycosaminoglycans and the regulation of blood coagulation.糖胺聚糖与血液凝固的调节
Biochem J. 1993 Jan 15;289 ( Pt 2)(Pt 2):313-30. doi: 10.1042/bj2890313.